Roberta Florido
( out of 26 reviews )

Roberta Florido, MD, MHS

Languages spoken: English, French, Portuguese, Spanish

Clinical Locations

Cardiovascular Center

Cardiovascular Center
Salt Lake City
801-585-5122

University of Utah Hospital

Heart Failure Clinic
Salt Lake City
801-585-5122

  • Dr. Florido completed medical training at the Universidade Federal do Rio de Janeiro in Brazil, graduating cum laude. She received training in Internal Medicine at Boston University, where she was also selected to serve as a chief medical resident. She subsequently completed fellowships in cardiology and advanced heart failure at Johns Hopkins and a Master’s in Health Sciences at the Johns Hopkins Bloomberg School of Public Health, receiving numerous awards. She joined the faculty at Johns Hopkins in August of 2018, where she created and directed the cardio oncology program. In 2023 Dr. Florido joined the Advanced Heart Failure and Transplant group at the University of Utah as an Associated Professor and the Director of Cardio-Oncology.

    Dr. Florido has led several studies assessing the impact of lifestyle related factors such as physical activity and adiposity on reducing the risk of heart failure, both in the general population and in particular within high-risk subgroups. Additionally, she has examined the role of novel biomarkers of subclinical myocardial injury and fibrosis in the associations of physical activity and adiposity with incident heart failure. Within the field of cardio-oncology, she has examined the distribution of biomarkers of subclinical myocardial injury in cancer survivors as indicators of long-term heart failure risk. She has also studied the associations of cancer survivorship with cardiovascular disease events.

    Dr. Florido has clinical expertise in advanced heart failure, mechanical circulatory support, heart transplantation, and cardio-oncology. Her academic interests are in heart failure prevention and cardio oncology.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Cardiovascular Disease)
    Educational Commission for Foreign Medical Graduates

    Patient Rating

    4.9 /5
    ( out of 26 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 18, 2024
    UH HOSPITALS AND CLINICS

    Compassionate, complete knowledgeable care. Dr. Florido has access to the latest information and how it impacts my heart health and care.

    October 07, 2024
    UH HOSPITALS AND CLINICS

    Kind mannerisms and professional through all parts of the visit. Did not make me feel as though she had to leave and get to other patients. She took the time to listen to me make the appropriate changes to my medication and clarify my care going forward.

    September 09, 2024
    UH HOSPITALS AND CLINICS

    Dr. Roberta Florido is wonderful to work with. She is kind and really cares about the patient. She is a dr. I would recommend her to anyone looking for a cardiologist.

    September 05, 2024
    UH HOSPITALS AND CLINICS

    I have been seen, treated by and administered by dozens of medical staff and this hospital is excellent in every detail.

    May 20, 2024
    UH HOSPITALS AND CLINICS

    Very much on top of things her knowledge of heart problems was very reassuring. Thank you

    May 17, 2024
    UH HOSPITALS AND CLINICS

    She is absolutely awesome. I felt comfortable and I know she heard me. She offered reassurance and encouragement. I was totally impressed.

    May 14, 2024
    UH HOSPITALS AND CLINICS

    I really appreciated Dr Florido.

    May 14, 2024
    UH HOSPITALS AND CLINICS

    I could tell that Dr. Florido had read my past chart notes as well as the information sent from my oncologist. She had great bedside manners and was able to answer detailed questions. Highly recommend!

    April 26, 2024
    UH HOSPITALS AND CLINICS

    Very knowledgeable and respectful

    See More Patient Comments

  • Dr. Florido completed medical training at the Universidade Federal do Rio de Janeiro in Brazil, graduating cum laude. She received training in Internal Medicine at Boston University, where she was also selected to serve as a chief medical resident. She subsequently completed fellowships in cardiology and advanced heart failure at Johns Hopkins and a Master’s in Health Sciences at the Johns Hopkins Bloomberg School of Public Health, receiving numerous awards. She joined the faculty at Johns Hopkins in August of 2018, where she created and directed the cardio oncology program. In 2023 Dr. Florido joined the Advanced Heart Failure and Transplant group at the University of Utah as an Associated Professor and the Director of Cardio-Oncology.

    Dr. Florido has led several studies assessing the impact of lifestyle related factors such as physical activity and adiposity on reducing the risk of heart failure, both in the general population and in particular within high-risk subgroups. Additionally, she has examined the role of novel biomarkers of subclinical myocardial injury and fibrosis in the associations of physical activity and adiposity with incident heart failure. Within the field of cardio-oncology, she has examined the distribution of biomarkers of subclinical myocardial injury in cancer survivors as indicators of long-term heart failure risk. She has also studied the associations of cancer survivorship with cardiovascular disease events.

    Dr. Florido has clinical expertise in advanced heart failure, mechanical circulatory support, heart transplantation, and cardio-oncology. Her academic interests are in heart failure prevention and cardio oncology.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Cardiovascular Medicine
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Cardiovascular Disease)
    Educational Commission for Foreign Medical Graduates

    Education history

    Fellowship Advanced Heart Failure, Transplant Cardiology, and Mechanical Circulatory Support - John Hopkins University School of Medicine Fellow
    Graduate Training Cardiovascular Epidemiology - Johns Hopkins Bloomberg School of Public Health M.H.S.
    Fellowship Cardiovascular Diseases - John Hopkins University School of Medicine Fellow
    Residency Internal Medicine - Boston University School of Medicine Chief Resident
    Residency Internal Medicine - Boston University School of Medicine Resident
    Research Fellow Aging - Mayo Clinic Postdoctoral Research Fellow
    Professional Medical Medicine - Universidade Federal do Rio de Janeiro M.D.

    Selected Publications

    Journal Article

    1. Power JR, Dolladille C, Ozbay B, Procureur AM, Ederhy S, Palaskas NL, Lehmann LH, Cautela J, Courand PY, Hayek SS, Zhu H, Zaha VG, Cheng RK, Alexandre J, Roubille F, Baldassarre LA, Chen YC, Baik AH, Laufer-Perl M, Tamura Y, Asnani A, Francis S, Gaughan EM, Rainer PP, Bailly G, Flint D, Arangalage D, Cariou E, Florido R, Narezkina A, Liu Y, Sandhu S, Leong D, Issa N, Piriou N, Heinzerling L, Peretto G, Crusz SM, Akhter N, Levenson JE, Turker I, Eslami A, Fenioux C, Moliner P, Obeid M, Chan WT, Ewer SM, Kassaian SE, International ICI-Myocarditis Registry, Johnson DB, Nohria A, Zadok OIB, Moslehi JJ, Salem JE (2024). Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity. (Read full article)
    2. Echouffo-Tcheugui JB, Zhang S, Florido R, Pankow JS, Michos ED, Goldberg RB, Nambi V, Gerstenblith G, Post WS, Blumenthal RS, Ballantyne CM, Coresh J, Selvin E, Ndumele CE (2024). Galectin-3, Metabolic Risk, and Incident Heart Failure: The ARIC Study. J Am Heart Assoc, 13(6), e031607. (Read full article)
    3. Pavlovic N, Ndumele CE, Abshire Saylor M, Szanton SL, Lee CS, Shah AM, Chang PP, Florido R, Matsushita K, Himmelfarb C, Leoutsakos JM (2024). Identification of Fatigue Subtypes and Their Correlates in Prevalent Heart Failure: A Secondary Analysis of the Atherosclerosis Risk in Communities Study. Circ Cardiovasc Qual Outcomes, 17(2), e010115. (Read full article)
    4. Hawwash NK, Sperrin M, Martin GP, Joshu CE, Florido R, Platz EA, Renehan AG (2023). Overweight-years and cancer risk: A prospective study of the association and comparison of predictive performance with body mass index (Atherosclerosis Risk in Communities Study). Int J Cancer. (Read full article)
    5. Polter EJ, Blaes A, Wolfson J, Lutsey PL, Florido R, Joshu CE, Guha A, Platz EA, Prizment A (2023). Performance of the pooled cohort equations in cancer survivors: the Atherosclerosis Risk in Communities study. J Cancer Surviv. (Read full article)
    6. Hamo CE, Echouffo-Tcheugui JB, Zhang S, Florido R, Pankow JS, Michos ED, Goldberg R, Nambi V, Gerstenblith G, Post WS, Blumenthal RS, Ballantyne C, Selvin E, Coresh J, Ndumele CE (2022). Diabetes Duration and Subclinical Myocardial Injury: The Atherosclerosis Risk in Communities Study (ARIC). Clin Chem, 68(10), 1272-1280. (Read full article)
    7. Florido R, Daya NR, Ndumele CE, Koton S, Russell SD, Prizment A, Blumenthal RS, Matsushita K, Mok Y, Felix AS, Coresh J, Joshu CE, Platz EA, Selvin E (2022). Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study. J Am Coll Cardiol, 80(1), 22-32. (Read full article)
    8. Echouffo-Tcheugui JB, Ndumele CE, Zhang S, Florido R, Matsushita K, Coresh J, Skali H, Shah AM, Selvin E (2022). Diabetes and Progression of Heart Failure: The Atherosclerosis Risk In Communities (ARIC) Study. J Am Coll Cardiol, 79(23), 2285-2293. (Read full article)
    9. Florido R, Kwak L, Echouffo-Tcheugui JB, Zhang S, Michos ED, Nambi V, Goldberg RB, Hoogeveen RC, Lazo M, Gerstenblith G, Post WS, Blumenthal RS, Coresh J, Folsom AR, Selvin E, Ballantyne C, Ndumele CE (2022). Obesity, Galectin-3, and Incident Heart Failure: The ARIC Study. J Am Heart Assoc, 11(9), e023238. (Read full article)
    10. Giuliano K, Scheel P 3rd, Etchill E, Fraser CD 3rd, Suarez-Pierre A, Hsu S, Wittstein IS, Kasper EK, Florido R, Tandri H, Calkins H, Choi CW, Sharma K, Kilic A, Gilotra NA (2022). Heart transplantation outcomes in arrhythmogenic right ventricular cardiomyopathy: a contemporary national analysis. ESC Heart Fail, 9(2), 988-997. (Read full article)
    11. Hamo CE, Kwak L, Wang D, Florido R, Echouffo-Tcheugui JB, Blumenthal RS, Loehr L, Matsushita K, Nambi V, Ballantyne CM, Selvin E, Folsom AR, Heiss G, Coresh J, Ndumele CE (2022). Heart Failure Risk Associated With Severity of Modifiable Heart Failure Risk Factors: The ARIC Study. J Am Heart Assoc, 11(4), e021583. (Read full article)
    12. Goldberg RL, Freed KE, Klemans N, Fioretti R, Choi CW, Kilic A, Adamo L, Florido R, Sharma K, Gilotra NA, Hsu S (2021). Angiotensin Receptor-Neprilysin Inhibition Improves Blood Pressure and Heart Failure Control in Left Ventricular Assist Device Patients. ASAIO J, 67(12), e207-e210. (Read full article)
    13. Echouffo-Tcheugui JB, Zhang S, Florido R, Hamo C, Pankow JS, Michos ED, Goldberg RB, Nambi V, Gerstenblith G, Post WS, Blumenthal RS, Ballantyne CM, Coresh J, Selvin E, Ndumele CE (2021). Duration of Diabetes and Incident Heart Failure: The ARIC (Atherosclerosis Risk In Communities) Study. JACC Heart Fail, 9(8), 594-603. (Read full article)
    14. Florido R, Kwak L, Lazo M, Michos ED, Nambi V, Blumenthal RS, Gerstenblith G, Palta P, Russell SD, Ballantyne CM, Selvin E, Folsom AR, Coresh J, Ndumele CE (2020). Physical Activity and Incident Heart Failure in High-Risk Subgroups: The ARIC Study. J Am Heart Assoc, 9(10), e014885. (Read full article)
    15. Scheel PJ 3rd, Florido R, Hsu S, Murray B, Tichnell C, James CA, Agafonova J, Tandri H, Judge DP, Russell SD, Tedford RJ, Calkins H, Gilotra NA (2020). Safety and Utility of Cardiopulmonary Exercise Testing in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. J Am Heart Assoc, 9(3), e013695. (Read full article)
    16. Florido R, Lee AK, McEvoy JW, Hoogeveen RC, Koton S, Vitolins MZ, Shenoy C, Russell SD, Blumenthal RS, Ndumele CE, Ballantyne CM, Joshu CE, Platz EA, Selvin E (2018). Cancer Survivorship and Subclinical Myocardial Damage. Am J Epidemiol, 188(12), 2188-2195. (Read full article)
    17. Florido R, Zhao DI, Ndumele CE, Bluemke DA, Heckbert SR, Allison MA, Ambale-Venkatesh B, Liu CY, Lima J, Michos ED (2019). Change in Physical Activity and Cardiac Structure over 10 Years: The Multi-Ethnic Study of Atherosclerosis. Med Sci Sports Exerc, 51(10), 2033-2040. (Read full article)
    18. Porter AK, Schilsky S, Evenson KR, Florido R, Palta P, Holliday KM, Folsom AR (2019). The Association of Sport and Exercise Activities With Cardiovascular Disease Risk: The Atherosclerosis Risk in Communities (ARIC) Study. J Phys Act Health, 16(9), 698-705. (Read full article)
    19. Florido R, Kwak L, Lazo M, Nambi V, Ahmed HM, Hegde SM, Gerstenblith G, Blumenthal RS, Ballantyne CM, Selvin E, Folsom AR, Coresh J, Ndumele CE (2018). Six-Year Changes in Physical Activity and the Risk of Incident Heart Failure: ARIC Study. Circulation, 137(20), 2142-2151. (Read full article)
    20. Fretz A, McEvoy JW, Rebholz CM, Ndumele CE, Florido R, Hoogeveen RC, Ballantyne CM, Selvin E (2017). Relation of Lifestyle Factors and Life's Simple 7 Score to Temporal Reduction in Troponin Levels Measured by a High-Sensitivity Assay (from the Atherosclerosis Risk in Communities Study). Am J Cardiol, 121(4), 430-436. (Read full article)
    21. Florido R, Ndumele CE, Kwak L, Pang Y, Matsushita K, Schrack JA, Lazo M, Nambi V, Blumenthal RS, Folsom AR, Coresh J, Ballantyne CM, Selvin E (2016). Physical Activity, Obesity, and Subclinical Myocardial Damage. JACC Heart Fail, 5(5), 377-384. (Read full article)
    22. Chin K, Zhao D, Tibuakuu M, Martin SS, Ndumele CE, Florido R, Windham BG, Guallar E, Lutsey PL, Michos ED (2016). Physical Activity, Vitamin D, and Incident Atherosclerotic Cardiovascular Disease in Whites and Blacks: The ARIC Study. J Clin Endocrinol Metab, 102(4), 1227-1236. (Read full article)
    23. Florido R, Zhao D, Ndumele CE, Lutsey PL, McEvoy JW, Windham BG, Pankow JS, Guallar E, Michos ED (2016). Physical Activity, Parental History of Premature Coronary Heart Disease, and Incident Atherosclerotic Cardiovascular Disease in the Atherosclerosis Risk in Communities (ARIC) Study. J Am Heart Assoc, 5(9). (Read full article)
    24. Steiling K, van den Berge M, Hijazi K, Florido R, Campbell J, Liu G, Xiao J, Zhang X, Duclos G, Drizik E, Si H, Perdomo C, Dumont C, Coxson HO, Alekseyev YO, Sin D, Pare P, Hogg JC, McWilliams A, Hiemstra PS, Sterk PJ, Timens W, Chang JT, Sebastiani P, OConnor GT, Bild AH, Postma DS, Lam S, Spira A, Lenburg ME (2013). A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment. Am J Respir Crit Care Med, 187(9), 933-42. (Read full article)

    Review

    1. Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, Florido R, Gluckman TJ, Hucker WJ, Mehran R, Mess SR, Perino AC, Rodriguez F, Sarode R, Siegal DM, Wiggins BS (2020). 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee. [Review]. J Am Coll Cardiol, 76(5), 594-622. (Read full article)
    2. Hu JR, Florido R, Lipson EJ, Naidoo J, Ardehali R, Tocchetti CG, Lyon AR, Padera RF, Johnson DB, Moslehi J (2018). Cardiovascular toxicities associated with immune checkpoint inhibitors. [Review]. Cardiovasc Res, 115(5), 854-868. (Read full article)
    3. Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, Florido R, Hucker W, Mehran R, Mess SR, Pollack CV Jr, Rodriguez F, Sarode R, Siegal D, Wiggins BS (2017). 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. [Review]. J Am Coll Cardiol, 70(24), 3042-3067. (Read full article)
    4. Florido R, Smith KL, Cuomo KK, Russell SD (2017). Cardiotoxicity From Human Epidermal Growth Factor Receptor-2 (HER2) Targeted Therapies. [Review]. J Am Heart Assoc, 6(9). (Read full article)
    5. Bernis K, Florido R, Ndumele CE (2017). The effects of bariatric surgery on the cardiovascular system. [Review]. Curr Cardiovasc Risk Rep, 11, 21.
    6. Florido R, Elander A, Blumenthal RS, Martin SS (2015). Statins and Diabetes: Can Risks Outweigh Benefits? [Review]. Curr Cardiovasc Risk Rep, 9, 14.

    Book Chapter

    1. Florido R, Tchkonia T, Kirkland JL (2011). Aging and Adipose Tissue. In Masoro EJ, Austad SN (Eds.), Handbook of The Biology of Aging (7th Edition, pp. 119-39). Elsevier.

    Case Report

    1. Vaishnav J, Hsu S, Sharma K, Florido R, Lewsey S, Schulman SP, Chacko M, Kilic A, Choi CW, Gilotra NA (2020). Crossing the Bridge to Heart Transplantation: Biventricular Impella to Support an Unstable LVAD Patient. JACC Case Rep, 2(2), 173-177. (Read full article)
    2. Arvanitis M, Tuday E, Florido R, Hsu S, Choi CW, Sharma K, Schulman SP (2019). Systemic Capillary Leak Syndrome Presenting With Fulminant Recurrent Cardiogenic Shock. Circ Heart Fail, 12(8), e006097. (Read full article)

    Editorial

    1. Abovich A, Florido R (2023). Aortic Inflammation: A Predictor of Cardiovascular Disease Risk in Lymphoma Patients? JACC Adv, 2(2), 100283. (Read full article)

    Letter

    1. Florido R, Selvin E (2019). Response by Florido and Selvin to Commentary regarding article: "Cancer Survivorship and Subclinical Myocardial Damage: The Atherosclerosis Risk in Communities (ARIC) Study". [Letter to the editor]. Am J Epidemiol. (Read full article)

    Other

    1. Florido R, Ndumele CE (2016). How Obesity Can Affect Your Heart.
    2. Florido R, Michos ED (2015). Sitting Disease: Moving Your Way to a Healthier Heart.

    Video/Film/CD/Web/Podcast

    1. Duvall C, Jha K, Blumenthal RS, Florido R (2021). The Myriad Cardiovascular Effects of Obesity [Web]. American College of Cardiology. Available: https://www.acc.org/latest-in- cardiology/articles/2021/07/15/19/32/the-myriad-cardiovascular-effects-of-obesity.
    2. Fox N, Blumenthal RS, Cainzos Achirica M, Florido R (2020). Physical Activity and Heart Failure in High-Risk Subgroups [Web]. American College of Cardiology. Available: https://www.acc.org/latest-in-cardiology/articles/2020/05/15/07/48/physical- activity-and-heart-failure-in-high-risk-subgroups.
    3. Feldman D, Cuomo K, Blumenthal RS, Florido R (2020). A Closer Look at How to Manage Heart Failure. Evidence-based dietary and medication changes can help promote recovery and a higher quality of life [Web]. CardioSmart: American College of Cardiology. Available: https://www.cardiosmart.org/News-and-Events/2020/01/A-Closer-Look-at-How-to-Manage-Heart- Failure.
    4. Florido R (2018). Breast Cancer Treatment and Your Heart [Web]. Available: https://www.cardiosmart.org/Heart-Conditions/Breast-Cancer-Treatment-and-Your-Heart.
    5. Florido R, Blumenthal RS, Martin SS (2015). Insights into Statin-Associated Diabetes: How Important is the Risk and How Should You Counsel Your Patient? [Web]. American College of Cardiology. Available: http://www.acc.org/latest- incardiology/articles/2015/01/06/08/57/insights-into-statin-associated-diabetes.